Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL
Conditions
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
Interventions
- DRUG: Acalabrutinib (Arm A)
- DRUG: Acalabrutinib (Arm B)
Sponsor
Acerta Pharma BV
Collaborators